title: Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2.
abstract: CCR5 is a G protein-coupled receptor for RANTES, MIP-1alpha, MIP-1beta, and MCP-2 that functions as the front line coreceptor for human immunodeficiency virus type 1 infection. To elucidate the mechanism for CCR5 activation, this coreceptor was expressed in yeast coupled to the pheromone response pathway and a constitutively active mutant (CAM) was derived by random mutagenesis. Conversion of Thr-82 in the highly conserved TXP motif in transmembrane helix 2 to Pro, His, Tyr, Arg, or Lys conferred autonomous signaling activity in yeast and mammalian cells. This substitution also imparted constitutive signaling to CCR2 in yeast and mammalian cells, but not CCR1, CCR3, CCR4, CXCR2, or CXCR4. The CCR5-CAM, but not the CCR2-CAM had a reduction in ligand binding affinity. Whereas the amplitude of calcium mobilization induced by RANTES stimulation was lower in the CCR5-CAM than the wild-type (WT) receptor, MCP-1 induced a higher signal in the CCR2-CAM than in CCR2-WT. The chemotactic response of CCR5-CAM(T82P) to RANTES was similar to that of CCR5-WT, but CCR5-CAM(T82K) was dramatically decreased. The chemotactic response of CCR2-WT and CCR2-CAM(T94K) were similar. These findings extend insight into the role of the TXP motif in the mechanism for CCR5 signaling. CCR2, the receptor most closely genetically related to CCR5, shared a similar signaling mechanism, but other receptors containing the TXP motif did not. The expression of CCR5 and CCR2 in yeast and the availability of variants with autonomous signaling represent critical tools for characterizing receptor antagonists and developing approaches to block their role in human diseases.
authors.affiliation: Department of Pathology, Medical College of Georgia, Augusta, Georgia 30912, USA.
authors.forename: Diana
authors.initials: D
authors.lastname: Alvarez Arias
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Navenot
authors.forename: Wen-Bo
authors.initials: WB
authors.lastname: Zhang
authors.forename: James
authors.initials: J
authors.lastname: Broach
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Peiper
mesh_terms: D020816:Amino Acid Motifs; D000818:Animals; D016466:CHO Cells; D002465:Cell Movement; D018946:Chemokine CCL5 / Q000378:metabolism; D002633:Chemotaxis; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D015723:Gene Library; D017930:Genes, Reporter; D016244:Guanosine 5'-O-(3-Thiotriphosphate) / Q000378:metabolism; D006801:Humans; D008024:Ligands; D009154:Mutation; D016366:Open Reading Frames; D010957:Plasmids / Q000378:metabolism; D011485:Protein Binding; D011487:Protein Conformation; D054390:Receptors, CCR2; D019713:Receptors, CCR5 / Q000378:metabolism*; D019707:Receptors, Chemokine / Q000378:metabolism*; D015398:Signal Transduction; D013912:Threonine / Q000737:chemistry
chemical_list: C515334:CCR2 protein, human; D018946:Chemokine CCL5; D008024:Ligands; D054390:Receptors, CCR2; D019713:Receptors, CCR5; D019707:Receptors, Chemokine; D013912:Threonine; D016244:Guanosine 5'-O-(3-Thiotriphosphate)